MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'baylor college of medicine'. Sat, 03 Sep 2011 02:38:33 +0100 http://www.medworm.com/index.php?rid=4298767&cid=t_145839_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2010%2F12%2F29%2Fuh-biochemist-works-to-revolutionize-ovarian-cancer-treatment-by-unleashing-the-power-of-micrornas-nanotechnology%2F The day when an ovarian cancer patient can treat her tumor with a single, painless pill instead of a toxic drug cocktail is the ultimate goal of the pioneering research of a University of Houston (UH) scientist.  Preethi Gunaratnee, assistant professor in the department of biology and biochemistry, is studying a class of tiny genetic [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=4298767 Wed, 29 Dec 2010 23:01:17 +0100 4298767 http://www.medworm.com/index.php?rid=3994013&cid=t_145839_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F09%2F21%2Fsleep-better-with-14-proven-strategies%2F For you, the idea of sleeping well might be as far-fetched as a unicorn sighting. And in our productivity-driven society, sleep is usually the first thing to get sacrificed. So many of us believe we need to focus on our priorities that we forget sleep is actually one of them. “Prioritizing sleep is important to overall health and quality of life,” said Mary Rose, Psy.D, clinical psychologist and behavioral sleep specialist at the Baylor College of Medicine. Read on for the 14 proven ways you can improve the quantity and quality of your sleep today. (Source: World of Psychology) World of Psychology blogs http://www.medworm.com/rss/comments.php?id=3994013 Tue, 21 Sep 2010 17:05:59 +0100 3994013 http://www.medworm.com/index.php?rid=3761627&cid=t_145839_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Ff0D61tLDo6E%2F Three years ago, Steve Haffner briefly gained notoriety when he leeked a meta-analysis of GlaxoSmithKline’s Avandia diabetes that was to be published in The New England Journal of Medicine. At the time, Haffner served as a peer reviewer and the breach allowed the drugmaker to respond very quickly to publication. But a recent US Senate Finance Committee investigation shows his ties to Glaxo were complicated - he was the lead author on an Avandia paper that was apparently ghostwritten before appearing in Circulation (back story here and here). A Glaxo spokeswoman has denied any ghostwriting took place and maintains Haffner authored the paper, providing “substantial input.” Moreover, she says the drugmaker follows accepted “authorship practices.” But Baylor Colle... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3761627 Fri, 16 Jul 2010 15:53:03 +0100 3761627 http://www.medworm.com/index.php?rid=3189400&cid=t_145839_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FcSz5onqH0Ls%2F For only the second time, the National Institutes of Health is applying pressure to a university over alleged conflicts of interest involving its researchers. The Baylor College of Medicine in Houston, Texas, is reportedly being eyed for failing to comply with the agency’s conflict of interest policy. Two years ago, the NIH suspended a grant from Emory University and added new conditions on further grants. The latest move was sparked by an article in The Chronicle of Higher Education that pointed out several academics with alleged research conflicts, including Baylor’s Christie Ballantyne, who received over $34,000 for consulting with Merck about its Vytorin cholesterol pill. This prompted US Senator Chuck Grassley to ask the NIH to investigate (see here), since Ballantyne was ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3189400 Wed, 20 Jan 2010 16:43:13 +0100 3189400 http://www.medworm.com/index.php?rid=2931286&cid=t_145839_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F6qSn-qjUnrs%2F The move is the latest in a long-running effort by the Republican Senator from Iowa, who has been probing undisclosed financial conflicts of interest among academics who simultaneously receive grants from the National Institutes of Health and payments from drug makers for research or speaking. His latest letter to the NIH follows an article in The Chronicle of Higher Education that noted several academics with alleged research conflicts. In particular, he cited Dr. Christie Ballantyne of the Baylor College of Medicine, who received over $34,000 for consulting with Merck about the Vytorin cholesterol pill. At the same, Grassley writes, Ballantyne was listed on several NIH grants concerning cardiovascular studies (here’s one). According to current NIH regulations, which Grassley has ci... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2931286 Tue, 27 Oct 2009 15:47:43 +0100 2931286 http://www.medworm.com/index.php?rid=2348539&cid=t_145839_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F04%2F18%2Fwhen-is-it-okay-to-hug-your-therapist%2F To hug or not to hug a client — that is the question that can haunt therapists. When a client is so distraught and you have no more words to offer, is physical contact a good idea? Glen O. Gabbard, M.D., Brown Foundation Chair of Psychoanalysis and professor of psychiatry at the Baylor College of Medicine in Houston, doesn’t seem to think so. In an April 2008 Psychiatric Times article, he talked about the trouble therapists can find themselves in if they do not follow American Psychological Association (APA) ethical and legal guidelines. Transference, in which therapy clients transfer feelings—positive or negative—for someone in their past to someone, such as a therapist, in their present—can help small transgressions, such as physical contact (including hugs) or... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=2348539 Sat, 18 Apr 2009 12:00:13 +0100 2348539 http://www.medworm.com/index.php?rid=1773566&cid=t_145839_136_f&fid=37846&url=http%3A%2F%2Fhealthinfoispower.wordpress.com%2F2008%2F09%2F07%2Fmk-0457-alone-and-in-combination-with-docetaxel-inhibits-ovarian-cancer-growth-in-vivo%2F …[T]he [M.D. Anderson Cancer Center & Baylor College of Medicine] researchers concluded that [Aurora kinase] AK inhibition [produced by MK-0457] significantly reduces ovarian cancer tumor burden and cell proliferation, and increases tumor cell apoptosis in preclinical ovarian cancer mouse models. The researchers noted that the role of Aurora kinase inhibition in ovarian cancer merits further [...] (Source: Libby's H*O*P*E*) Libby's H*O*P*E* blogs http://www.medworm.com/rss/comments.php?id=1773566 Mon, 08 Sep 2008 00:49:39 +0100 1773566 http://www.medworm.com/index.php?rid=1126437&cid=t_145839_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F209905889%2F Two Baylor College of Medicine scientists have developed a cocaine vaccine, currently in clinical trials, that stimulates the immune system to attack the real thing when it’s taken, The Houston Chronicle reports. As a result, cocaine no longer provides a kick. “For people who have a desire to stop using, the vaccine should be very useful,” Tom Kosten, a psychiatry professor who was assisted in the research by his wife, Therese, a psychologist and neuroscientist, tells the paper. “At some point, most users will give in to temptation and relapse, but those for whom the vaccine is effective won’t get high and will lose interest.” Last month, Kosten asked the FDA to okay a multi-institutional trial to begin in the spring, which presumably would be the final ... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1126437 Wed, 02 Jan 2008 13:59:25 +0100 1126437 http://www.medworm.com/index.php?rid=888598&cid=t_145839_145_f&fid=35710&url=http%3A%2F%2Fksdescartin.wordpress.com%2F2007%2F09%2F20%2Fan-evening-of-more-than-the-past-present-future-part-1%2F Yesterday, September 19th was the kick off for the series of lectures at the Continuing Studies program at Rice University. It was at Sewall Hall at the Rice Campus. Dr. Denton A. Cooley, the pioneer of human heart transplant in the United States, still observably sprightly at 87, was the lecturer for the day. He is currently president and surgeon-in-chief at the Texas Heart Institute; program director for the Texas Heart Institute/Baylor College of Medicine Thoracic Residency Program; and chief of cardiovascular surgery at St. Luke’s Episcopal Hospital. Here are some of my notes on this experience. Dr. Cooley, His Influences, and The People He Worked With He performed the first successful human heart transplant in the United States in 1968. In 1969, he became the first heart surgeon to ... the story of healing blogs http://www.medworm.com/rss/comments.php?id=888598 Thu, 20 Sep 2007 19:25:33 +0100 888598